Stablishment of Prevention and Treatment System for Intestinal Dysfunction

• Status: Not yet recruiting
• Trial end date: 2023-09-30
• Target enrollment: 0
• Participant gender: All

Summary

Dysfunction and intestinal endocrine dysfunction. This project will use genomics, metabonomics, microbiome and other omics techniques to study the clinical pathway of CID integrated therapy.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nanjing University School of Medicine

Criteria

Inclusion Criteria:

• The Patients with chronic bowel dysfunction

Exclusion Criteria:

• Past severe underlying diseases of the respiratory system and cardiovascular system,

• Allergy to treatment-related drugs,

• Pregnancy,

• Accept CID surgery.